Woodmont Investment Counsel’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,013
Closed -$444K 217
2021
Q3
$444K Buy
7,013
+4,310
+159% +$328K 0.06% 154
2021
Q2
$247K Buy
+2,703
New +$215K 0.04% 178
2021
Q1
Sell
-3,073
Closed -$223K 194
2020
Q4
$223K Buy
+3,073
New +$178K 0.04% 164
2019
Q3
Sell
-11,184
Closed -$402K 169
2019
Q2
$402K Sell
11,184
-1,195
-10% -$38.3K 0.1% 133
2019
Q1
$390K Sell
12,379
-11,700
-49% -$341K 0.1% 136
2018
Q4
$605K Buy
24,079
+6,200
+35% +$159K 0.17% 116
2018
Q3
$516K Sell
17,879
-18,870
-51% -$353K 0.14% 118
2018
Q2
$450K Sell
36,749
-54,306
-60% -$623K 0.12% 123
2018
Q1
$726K Buy
91,055
+6,866
+8% +$42.3K 0.2% 105
2017
Q4
$618K Buy
+84,189
New +$525K 0.16% 118

Other funds holding CDNA

Woodmont Investment Counsel's CDNA Position: Q4 2021 in Review

Woodmont Investment Counsel sold out of CareDx (CDNA) in Q4 2021, closing a stake of 7,013 shares — an estimated $444K sold.

Woodmont Investment Counsel first reported a position in CDNA in Q4 2017 and held it in 10 quarters. The position peaked at $726K in Q1 2018. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Woodmont Investment Counsel reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Woodmont Investment Counsel sold 7,013 CareDx shares in Q4 2021, an estimated $444K.
  • Woodmont Investment Counsel first reported a position in CareDx in Q4 2017 and held it in 10 quarters.
  • Woodmont Investment Counsel's CareDx position peaked at $726K in Q1 2018.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Woodmont Investment Counsel's 13F filing for Q4 2021, filed 2 Feb 2022.